Remove 2002 Remove COVID-19 Remove Hospitals Remove Licensing
article thumbnail

SQA Regulatory Surveillance Summary 1 | Monthly Update 2021

SQA

NMPA Adjusts Classification Catalog and Down-Classifies Some Medical Devices, 19 January 2021. China’s UDI pilot program wrapped up at the close of 2020; it was previously slated to end in October, but the NMPA extended this trial period due to the impact of the COVID-19 pandemic. China Guidances and Regulations.

article thumbnail

SQA Regulatory Surveillance Summary | Monthly Update 2022 – June

SQA

ANVISA published the RDC 702/2022, which repeals some requirements that were instituted to speed market approval of devices needed to treat patients during the height of the COVID-19 pandemic. The Regulations were first issued with immediate effect in 2002 and were later revised in 2016.

FDA 91
article thumbnail

SQA Regulatory Surveillance Summary | Monthly Update 2024

SQA

The MHRA has received reports of a very small number of people who have been hospitalized after using potentially fake pens. These are requirements of the Therapeutic Goods (Medical Devices) Regulations 2002. Buying prescription-only medicines online without a prescription poses a direct danger to health.

FDA 52